The Fourth BIOINC Pitch-To-Portfolio Competition Continus to Put Mansfield Bio-Incubator on the Map.

MANSFIELD, MA – November 25, 2025 - The Fourth BIOINC Pitch-to-Portfolio Competition, held on November 13, 2025, was another memorable event in the string of pitch competitions that brought collectively 68 pitches, $280K in awards, and 550 attendees. A true legacy and evidence of the well-established and vibrant BIOINC life science ecosystem.  What began as a regional pitch event has now evolved into a truly international platform for scientific innovation and entrepreneurial excellence.

This pitch competition featured a keynote address by US Congressman Jake Auchincloss (D) followed by a pointed Q&A session. In his keynote, Rep Auchincloss emphasized that many of the scientific entrepreneurs were immigrants. He thanked them for building here and encouraged them to feel welcome in Massachusetts not let anyone make them feel less than fully American. He stressed the idea that the nation is not based on blood and soil but rather on the ideas of freedom, natural rights, and equality. During the Q&A session, Jake implored everyone in the audience ot pick one issue that resonates with each individual and keep pushing for scientific progress, prosperity, and equality despite the political headwinds.

As usual, a wide range of life science sectors were presented, including therapeutics, diagnostics, and medical devices, and natural products.

All-investor judging panel of 6 awarded the following companies

First Place: Soltego, presented by Inbal Rachmin, VP of R&D

Second Place: Asparaglue, presented by Paul Birkmeyer, CEO

Third Place: Lambda Surgical, presented by Roman Stolyarov, CEO

It was a tough competition, places were separated by single points from each other and from the rest of the pack.

Brown University Partnership

This competition also features a new collaboration with Brown University, which presented five graduate-level biotech venture teams in a 90-second elevator-pitch format. These student-led ventures, developed through Brown’s advanced biotechnology management program, represent investment-ready concepts supported by early technical validation and market analysis: Tanzanite Therapeutics (Alissa Lui), NuroNova (Saachi Gandhi), OncoTrack Technologies (Siddarth Vinod Kumar), pHera Therapeutics (Nidhi Pawar), LumiNeura Imaging (Nastassja Matus).

“We’re thrilled to continue the momentum from our first three competitions,” said Russ Yukhananov, President of Mansfield BioIncubator. “These pitch competitions are becoming a cornerstone of our mission to support innovation and connect startups with entrepreneurs, investors, and industry professionals within Mansfield BIOINC's growing life science ecosystem.”

The pitch competition was generously sponsored by MilliporeSigma, SIno Biological, Slowey McManus, ADP, CMIC, Cytosurge, CliftonLarsonAllen (CLA), and Polsinelli. We are extremely grateful for support!

About Mansfield BioIncubator

Mansfield BIOINC supports early-stage life-science companies through mentoring programs, pitch competitions, investor access, networking, and state-of-the-art lab and office facilities. Its mission is to foster innovation in healthcare by accelerating startup growth and success.

241 Francis Ave, Mansfield, MA 02048

📧 info@bioinc.org

Mansfield Bio-Incubator Announces Lineup and Judges for the Fourth $80K Pitch-to-Portfolio Competition on November 13, 2025

MANSFIELD, MA — Mansfield BioIncubator proudly announces the first cohort of startups selected for the Fourth BIOINC Pitch-to-Portfolio Competition, awarding $80,000 in prizes on November 13, 2025.

Six BIOINC member companies have advanced through the qualification round and will compete across therapeutics, devices, diagnostics, and digital health:

·       Modunai Therapeutics — Disarming cancer resistance with first-in-class bispecifics and ADCs targeting stress pathways

·       Alnivo Therapeutics — Unlocking the therapeutic potential of HSP70 in regeneration and repair

·       Diopter Technologies — BioShare biopolymer amniotic membrane lens for ocular surface disease

·       AlphaCure Therapeutics — Precision radioligand therapy to cure cancer

·       DeepCovalent — One-step drug discovery

·       Liseva Bio — Turning therapeutic cells into resilient cell medicines

Additional contestants will be added pending final qualification.

Each participant will deliver a 5-minute investor-focused pitch, gaining visibility, mentorship, and access to BIOINC’s borderless life-science ecosystem — designed to accelerate startup success and investor engagement.

Brown University Partnership

This year’s event features a new collaboration with Brown University, which will present five graduate-level biotech venture teams in a rapid-fire elevator-pitch format. These student-led ventures, developed through Brown’s advanced biotechnology management program, represent investment-ready concepts supported by early technical validation and market analysis.

Judging Panel

The competition will be evaluated by an all-investor panel, including:

David Fogel, Managing Director, Swifton

Jeff Berman, Co-Founder, Big Tree Innovation Fund

Stacy Swider, MassVentures

Danielle O’Neal, Life Sciences, Banc of California

Luke Diehl, Longshot Ventures

Michael Partridge, Macpherson Capital Advisors

 

“The diversity of this year’s competitors — along with the global footprint of participating startups — highlights the continued growth of our life-science ecosystem,” said Russ Yukhananov, President of Mansfield Bio-Incubator. “This event provides emerging companies with visibility, expert mentorship, valuable investor connections, and a pathway to funding.”

To attend or request more information, contact: Alex Shlyankevich, PhD — Director of Investments📧 alexsh@bioinc.org

Register to attend

About Mansfield BioIncubator

Mansfield BIOINC supports early-stage life-science companies through mentoring programs, pitch competitions, investor access, networking, and state-of-the-art lab and office facilities. Its mission is to foster innovation in healthcare by accelerating startup growth and success.

241 Francis Ave, Mansfield, MA 02048

📧 info@bioinc.org

Mansfield Bio-Incubator Welcomes Cryoveritas as a Member Company.

Mansfield, MA- Mansfield Bio-Incubator is excited to welcome Cryoveritas into a 60+-strong membership community!

CryoVeritas is pleased to announce that our product, Pinktail BX0C, is now available through Avantor/VWR (Market Source catalog) and Thermo Fisher Scientific (Encompass catalog)!

We are currently offering free product samples to labs and life science companies.

A simple, visual temperature indicator that makes it easy to verify whether your frozen or ultracold samples have stayed protected during storage and transport.

KEY FEATURES

  • Instant visual alerts – Turns pink to clear if exposed to temperatures above threshold.

  • Works down to –80°C – Perfect for vaccines, cell therapies, and biological samples.

  • No batteries, no calibration – Always ready, unlike traditional data loggers.

  • Affordable and scalable – Ideal for large-volume cold chain distribution.

APPLICATIONS

  • For Research & Biotech Teams: Peace of mind during cold storage, shipment, and sample handoffs.

  • For Logistics & Distributors: Enhance packaging compliance and reduce spoilage risk—without adding complexity.

We’re proud to support labs, CROs, and biopharma partners who are building the future of healthcare.

For more information and to order, please visit https://www.cryoveritas.com

The Third BIOINC Pitch Competition: From Local Momentum to Global Reach

MANSFIELD, MA - July 1, 2025-The Third BIOINC Pitch Competition, held on June 12, 2025, was more than a showcase—it was a moment of transformation for our growing life science ecosystem. What began as a regional pitch event has now evolved into a truly international platform for scientific innovation and entrepreneurial excellence.

This year, for the first time, we welcomed contestants based outside the U.S.—and they didn’t just participate. They took all the prizes.

First Place: H-BOX Therapies (Germany) Presented by Matthias Menne, Managing Director and Co-CEO

Second Place (tie): – NeoGap Therapeutics (Sweden), presented by Samuel Svensson, CEO – Neshima Medical (Israel), presented by Yan Ostrovski, CEO

So yes, it was a clean sweep for our international guests. American startups—watch out. The global field is not just competitive. It’s winning.

But the international presence wasn’t the only pattern that stood out. The BIOINC Mentoring Program, now in its second year, once again proved to be a launchpad for success. H-BOX, our first-place winner, is a recent graduate of the program—just as all three prize winners at the Second Pitch Competition were Mentoring alumni. It’s becoming a trend: if you want to stand out at BIOINC, start with the Mentoring Program.

We also ran our now-popular 1-Minute Elevator Pitch Challenge, featuring 11 companies from the European Innovation Center (EIC) Soft-Landing Program. Each startup had just 60 seconds to pitch in front of a live audience, emulating the classic scenario: you’re in an elevator with an investor—what do you say to earn the next meeting?

Audience Award Winner: Surgify (Finland) Presented by Visa Sippola, CEO Prize: One-year free basic business membership at BIOINC

What also made this pitch competition memorable is another competitor—but of a slightly different kind: three-time Super Bowl champion Joe Andruzzi. In his current capacity, Joe represents the Joe Andruzzi Foundation, which provides financial support to New England cancer patients.

If the First Mansfield Pitch Competition put BIOINC on the map, the Second established its legacy, then the Third expanded it to a truly global scale.

Where do we go from here? The Fourth BIOINC Pitch Competition, coming this fall, will show us. Stay tuned.

Mansfield Bio-Incubator Expands Competitor Roster and Adds International Presenters for $80K Pitch Competition on June 12, 2025

MANSFIELD, MA – May 30, 2025 – Mansfield Bio-Incubator is proud to announce an expanded lineup for the Third BIOINC Pitch Competition, offering $80,000 in prizes and highlighting some of the most promising innovations in the life sciences.

The upgraded competition will feature 14 member companies, selected through a rigorous internal review process across key sectors including therapeutics, medical devices, diagnostics, and digital health. The expanded roster reflects the BIOINC ecosystem’s continued growth, now enriched by outstanding companies from both the U.S. and internationally.

·       Opprtna Therapeutics – Empowering health through precision aptamer therapeutics.

·       Trivoke Therapeutics – Harnessing innate and adaptive immunity for immediate tumor control and lasting cancer defense.

·       Stapgen – Pioneering the early detection and prevention of Type 2 Diabetes.

·       Predictive Healthcare – An AI-based postoperative surgical site infection monitoring.

·       HBOX Therapies – Revolutionizing respiratory support.

·       Neshima Medical – A paradigm-shifting technology for the delivery of therapeutics to the lungs.

·       Novaurum BioSciences – Pioneering nanotechnology for life-changing medical devices.

·       Microvitality – Revolutionizing the fields of gastroenterology and precision medicine by unlocking the power of the microbiome.

·       Lyme Alert – Pioneering the first home test kit for Lyme disease.

·       O11 Biomedical – The disruptive MoA in Chronic Obstructive Pulmonary Disease treatment: Breathing via the gut.

·  NeoGap Therapeutics - Personalized cancer immunotherapy.

·  AlphaCure Therapeutics – Curing cancer with precision radioligand therapy.

· Renosome Bio -Exosome-mediated regenerative medicines.

· Rhogen Biotech –  A next-generation tumor colonizing probiotic targeting angiogenesis in colorectal cancer.

More coming! Stay tuned.

Participants will deliver a 5-minute pitch, taking advantage of this unique opportunity to gain visibility, receive mentorship, and compete for funding. The BIOINC Pitch Competition series also acts as a gateway for attracting investors and exploring the benefits of participating in BIOINC’s borderless life science ecosystem.

The six-member Judging Panel will consist of investors, industry, and academic experts: David Fogel (Swifton, Managing Director, Investor), Eugene Buff (Director of Health Science Entrepreneurship and Innovation, Northeastern University), Jeff Berman (Co-Founder, Big Tree Innovation Fund), Courtney Metz (Site Head, Harvard Life Labs, LabCentral), James Ehret (Managing Director, Life Sciences, Bank of California) and Pranjul Shah (MIT, Investor)

A major highlight of this year’s event is the participation of a dozen European life science ventures, which will be featured in non-competing one-minute pitches. These companies are part of a strategic internationalization initiative supported by the European Innovation Council (The EIC Soft-Landing Programme in Boston), Europe’s largest public venture capital fund, managing more than €10 billion in assets.

“We are excited to see these premier startups brought by the European Innovation Council,” said Russ Yukhananov, President of Mansfield Bio-Incubator. “We look forward to opening BIOINC doors to them to establish their presence in the US”.

For more information, contact Alex Shlyankevich, Director of Investments, at alexsh@bioinc.org.

Register to attend

About Mansfield Bio-Incubator

Through its ecosystem activities, Mansfield Bio-Incubator offers comprehensive support to early-stage life science companies, including mentoring programs, pitch competitions, networking opportunities, investor exposure, MassBio/MassMEDIC memberships, and state-of-the-art laboratory and office space. Its mission is to foster innovation in healthcare by assisting startups in navigating growth and development challenges.

For media inquiries, please contact: info@bioinc.org

Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048

Mansfield Bio-Incubator Reveals Contestants and Judging Panel for $80K Pitch Competition on June 12, 2025

MANSFIELD, MA – May 12, 2025 – Mansfield Bio-Incubator proudly announces the Third BIOINC Pitch Competition line-up, offering $80,000 in prizes. The competition is set to take place on June 12, 2025.

The event will feature seven members of the Mansfield Bio-Incubator, who went through selection rounds across various sectors: therapeutics, devices, diagnostics, and digital health.

·       Opprtna Therapeutics – Empowering health through precision aptamer therapeutics.

·       Trivoke Therapeutics – Harnessing innate and adaptive immunity for immediate tumor control and lasting cancer defense.

·       Boston Interactome – Decoding the human protein interactome for next generation therapies.

·       Stapgen – Pioneering the early detection and prevention of Type 2 Diabetes.

·       Predictive Healthcare – An AI-based postoperative surgical site infection monitoring.

·       Neshima Medical – A paradigm-shifting technology for the delivery of therapeutics to the lungs.

·       Novaurum BioSciences – Pioneering nanotechnology for life-changing medical devices

A limited number of contestants may be added to the roster if they meet the qualification requirements.

Participants will deliver a 5-minute pitch, taking advantage of this unique opportunity to gain visibility, receive mentorship, and compete for funding. The BIOINC Pitch Competition series also acts as a gateway for attracting investors and exploring the benefits of participating in BIOINC’s borderless life science ecosystem.

The five-member Judging Panel will consist of investors, industry and academic experts:

David Fogel (Swifton, Managing Director), Eugene Buff (Director of Health Science Entrepreneurship and Innovation, Northeastern University), Jeff Berman (Co-Founder, Big Tree Innovation Fund), Courtney Metz (Site Head, Harvard Life Labs, LabCentral), James Ehret (Managing Director, Life Sciences, Bank of California).

“The diversity of fields represented in this year’s competition, along with the global footprint of the participating startups, reflects the continued momentum of our thriving life science ecosystem,” said Russ Yukhananov, President of Mansfield Bio-Incubator. “This event offers an exceptional opportunity for emerging companies to increase visibility, build valuable connections, benefit from expert mentorship, and attract the funding needed to propel their innovations forward.”

For more information, contact Alex Shlyankevich, Director of Investments, at alexsh@bioinc.org.

Register to attend

About Mansfield Bio-Incubator

Through its ecosystem activities, Mansfield Bio-Incubator offers comprehensive support to early-stage life science companies, including mentoring programs, pitch competitions, networking opportunities, investor exposure, MassBio/MassMEDIC memberships, and state-of-the-art laboratory and office space. Its mission is to foster innovation in healthcare by assisting startups in navigating growth and development challenges.

For media inquiries, please contact: info@bioinc.org

Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048

Mansfield Bio-Incubator (BIOINC) Fosters Collaborations between Startups and Colleges-Partnerships in Action

Mansfield, MA (March 31, 2025) — One of the critical missions of startup incubators is to help train the future workforce by providing various experiential learning opportunities. Over the past year Mansfield Bio-Incubator (BIOINC) engaged in two separate partnerships to achieve this goal. First, Northeastern University and the Mansfield BioIncubator (BioInc) partnered to offer the first student co-op at the leading venue for biotechnology and life sciences innovation in southeastern Massachusetts. In addition, two pioneering startups housed at BioInc, Stapgen and UpLevel Foods, are harnessing a strategic partnership with Catawba College's Entrepreneurship Practicum to propel advancements in life sciences and functional foods. These workforce development collaborations equip both startups and higher education institutions with opportunities to enhance their trajectories and to foster innovation in an increasingly competitive landscape.

Northeastern University and BioInc

Northeastern University has been running a signature "co-op" program for 115 years. The program offers students full-time, months-long professional work experience and is a key part of the university's experiential learning approach. For the Fall 2024 Semester, Mansfield Bio-Incubator hosted Ms. Linh Dinh, a student working on MS in Project Management at Northeastern University. ”My experience at Mansfield Bio-Incubator greatly expanded my knowledge of the startup world and especially gave me the appreciation of high risks and potentially high rewards associated with the Life Science industry. I am grateful for this opportunity”, said Ms Linh Dinh.

Revolutionizing Diabetes Detection and Nutritional Health

Stapgen, focused on preempting Type 2 Diabetes, has leveraged the collaborative efforts with Catawba College to refine its innovative STAP Test. This diagnostic tool is designed to predict diabetes risk years before clinical symptoms manifest. Dr. Biplab K. Malo, founder of Stapgen, stated, “Working with the bright minds at Catawba College has allowed us to sharpen our go-to-market approach and enhance our diagnostic accuracy.”

UpLevel Foods, creators of nutrient-dense condiments, has similarly benefited from the partnership, gaining deeper insights into consumer behavior and nutritional preferences. “The research conducted by Catawba students has been instrumental in shaping our product development and marketing strategies,” noted Soumya Roy, co-founder of UpLevel Foods. Their products aim to improve consumer health through everyday dietary choices, emphasizing the importance of nutrient enhancement.

Driving Impact Through Academic-Industry Synergy

The collaboration between the Mansfield Bioincubator and Catawba College's Entrepreneurship Practicum involves students working closely with startups to conduct market research, analyze industry trends, and develop actionable strategies. Under the guidance of seasoned entrepreneur and Mansfield Bioincubator Advisory Board Member Pabel Delgado, students gain hands-on experience while providing valuable insights to the startups.

“These collaborations provide both immediate and long-term benefits, creating a dynamic ecosystem where academic rigor meets entrepreneurial spirit,” commented Dr. Rustam (Russ) Yukhananov, President of the Mansfield Bio-incubator. “By combining the energy and creativity of students with the expertise of our startups, we accelerate the pace of life sciences innovation.”

Cultivating Entrepreneurial Talent

Delgado, an Advisory Board Member at the Mansfield Bioincubator and Entrepreneur-in-Residence at Catawba College, has been instrumental in shaping this partnership. Drawing from his extensive experience in integrating entrepreneurial learning into academic curricula, including his tenure as Professor of Practice at Wheaton College Massachusetts from 2022 to 2024, Delgado has led several initiatives that connected students with biotech startups, providing hands-on courses and year-long co-operative opportunities in areas such as cell culture and chemical analytics. Through these experiences, he has developed a robust framework for academic-industry collaboration.

“This collaboration isn't just about today's achievements; it's about building a sustainable pipeline of innovation for tomorrow's challenges in life sciences,” said Delgado. “By integrating real-world entrepreneurial challenges into the academic curriculum, we're creating a dynamic learning environment that prepares students for the rigors of the industry while providing startups with fresh perspectives and market insights.”

Future Directions and Continued Collaboration

The success of this partnership highlights the effectiveness of integrating academic resources with industry needs to drive life sciences innovation. Building on this proven model, the Mansfield Bioincubator is poised to launch a comprehensive Biotech Immersion Program in 2025. This intensive, multi-phase initiative will provide students with in-depth exposure to the biotech industry, combining rigorous coursework with hands-on projects at startups like Stapgen and UpLevel Foods. The program aims to further bridge the gap between theoretical knowledge and practical application, fostering a new generation of life sciences leaders.

As Stapgen and UpLevel Foods continue to grow and innovate, the support and resources provided by the Mansfield Bioincubator and its academic partnerships will remain essential to their success. “The Mansfield Bioincubator and Catawba College have crafted a model for collaboration that has the potential to transform the way we nurture life sciences entrepreneurship,” said Dr. Alexander Margulis, Chief Operating Officer of the Mansfield Bioincubator. “Together, we're breaking down barriers, fostering innovation, and creating opportunities for the next generation of leaders to drive meaningful change in the life sciences industry and beyond.”

About Northeastern University: Northeastern University is a private research university with its main campus in Boston, Massachusetts, United States and 13 global satellite campuses. With more than 38,000 students, Northeastern is the largest university in Massachusetts by enrollment.

About Stapgen: Stapgen is a biotech and medtech company that aims to transform diabetes management with its STAP Test, capable of detecting Type 2 Diabetes risk years before its onset. Their innovative approach to early detection and management seeks to significantly alter the healthcare landscape.

About UpLevel Foods: UpLevel Foods innovates in the functional foods market by producing nutrient-enhanced condiments designed to boost health and vitality. With each product, UpLevel Foods strives to set a new standard in nutritional value, directly impacting consumer health outcomes.

About Catawba College: Founded in 1851, Catawba College is a nationally recognized private liberal arts college located in Salisbury, North Carolina. Committed to providing students with a transformative educational experience, Catawba blends rigorous academics with hands-on learning opportunities that prepare graduates to become leaders in their chosen fields.

About the Mansfield Bioincubator: The Mansfield Bioincubator is a catalyst for early-stage life sciences innovation in the greater Boston area. Through its comprehensive suite of lab space, mentorship, and support services, the bioincubator empowers startups to develop groundbreaking solutions that address critical health challenges and improve lives.

For further information or to engage with these initiatives, please contact:

Dr. Alexander Margulis

Chief Operating Officer, Mansfield Bioincubator

(888) 490-4443

alex.margulis@bioinc.org

Mansfield Bio-Incubator (BIOINC) Announces Enrollment for the Third Cohort of the BIOINC Mentoring Program – Spring 2025 

 

MANSFIELD, MA – January 30, 2025 – Mansfield Bio-Incubator (BIOINC) is excited to announce that enrollment is now open for the third cohort of the BIOINC Mentoring Program, set to launch in Spring 2025. Following the success of the two 2024 cohorts—where six companies successfully graduated—this program continues to support the most promising life science startups in advancing their business and technical development. 

As a key benefit of BIOINC’s ecosystem membership, the Mentoring Program provides life science entrepreneurs with personalized guidance from industry veterans, helping them refine their technical expertise and business strategies. Participants will also be able to validate their progress by competing in the BIOINC Pitch Competition, where they can showcase their improved pitch decks and sharpen their investor presentations. Additionally, the program fosters invaluable networking opportunities, connecting participants with fellow entrepreneurs, investors, and industry leaders within BIOINC’s thriving life science community. 

The BIOINC Mentoring Program welcomes applications from startups across various sectors, including therapeutics, diagnostics, medical devices, and other life science industries. Additionally, experienced life science and business professionals are invited to join as mentors, contributing their expertise to shape the next generation of healthcare innovators. 

“We’re building on the momentum from our first two cohorts in 2024,” said Russ Yukhananov, President of BIOINC. “The Mentoring Program is becoming a centerpiece to our mission to support innovation and increase the likelihood of our startups securing funding.” 

For more information or to apply, contact: 
Julia Rashba-Step, Director of Mentorship 

Email:juliars@bioinc.org 

About BIOINC (Mansfield Bio-Incubator)
BIOINC (Mansfield Bio-Incubator) supports early-stage life science companies and commercial firms through a comprehensive ecosystem of services. Offerings include mentoring programs, pitch competitions, networking opportunities, investor access, connections to Massachusetts Life Science Center, MassBio/MassMEDIC memberships, and access to state-of-the-art laboratory and office space. Its mission is to drive healthcare innovation by empowering startups and established companies to grow and succeed in the market. 

Media Inquiries: 
Email:info@bioinc.org 
Address: Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048 

BIOINC (Mansfield Bio-Incubator) Announces the Third $80K BIOINC Pitch Competition on June 12, 2025

MANSFIELD, MA – January 30, 2025– BIOINC (Mansfield Bio-Incubator) is excited to announce the Third BIOINC Pitch Competition, scheduled for June 12, 2025. Building on the success of the two 2024 competitions, this event will showcase a new cohort of innovative life science startups with exceptional business potential.

The competition invites applications from startups in various sectors, including therapeutics, diagnostics, medical devices, digital health, and other life science fields. Participants will present a 5-minute pitch or a poster presentation, leveraging this unique opportunity to gain visibility, receive mentorship, and compete for vital funding to advance their cutting-edge solutions. This event is also a gateway to attracting investors and discovering the benefits of participating in BIOINC’s dynamic life science community.

The $80K prize package includes cash awards and lab space for the top three contestants. Additional special prizes will be announced closer to the event.

“We’re thrilled to continue the momentum from our first two competitions in 2024,” said Russ Yukhananov, President of BIOINC. “Pitch competitions are becoming a cornerstone of our mission to support innovation and connect startups with entrepreneurs, investors, and industry professionals within BIOINC’s growing life science ecosystem.”

For more information or to apply, contact: Alex Shlyankevich, Director of Investments Email: alexsh@bioinc.org

---

About Mansfield BioIncubator BIOINC (Mansfield Bio-Incubator) supports early-stage life science companies and commercial firms through a comprehensive ecosystem of services. Offerings include mentoring programs, pitch competitions, networking opportunities, investor access, connections to massachusetts Life Science Center, MassBio/MassMEDIC memberships, and access to state-of-the-art laboratory and office space. Its mission is to drive healthcare innovation by empowering startups and established companies to grow and succeed in the market.

Media Inquiries: Email: info@bioinc.org Address: Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048

Aclarity Graduated from Mansfield Bio-Incubator

MANSFIELD, MA - Last month, Aclarity, a leader in PFAS removal, officially completed the move from Mansfield Bio-Incubator to their new headquarters in Medway.  September 2022, the time when Aclarity became Mansfield Bio-Incubator’s member with less than five lab-based employees and taking up a bench in the shared space, seems like yesterday. It’s been fascinating to see the team’s growth in leaps and bounds while raising over $20 million and expanding its footprint in the building. Their infectious energy permeated the entire space during various team-building exercises and other activities.

Aclarity’s Team

“Mansfield Bio-Incubator has been an incredible partner for us. Both Alex Margulis, the COO and Russ Yukhananov, the President, went above and beyond to make sure we had the necessary physical space to accommodate our growing team and the R&D needs, upgrade and store our reactor in our mobile field trailer outside, and connect us with key leaders such as US Representative Jake Auchnicloss (D). Without their support, Aclarity would not have succeeded as fast as it did”, said Julie Bliss Mullen, Aclarity’s Chief Executive Officer.

At Mansfield Bio-Incubator, we are thrilled for Aclarity’s next chapter in their growth and wish them continued success. We currently support over 30 life science startup companies to achieve Aclarity’s success by offering a premier laboratory space. In addition, we offer supportive community, legal and business plan help, connections with investors, highly acclaimed mentor program, and a semi-annual pitch competition, to ensure the companies’ success. For more information on the laboratory space and other services and to become a member, please contact alex.margulis@bioinc.org or (888) 490-4443 x4 or visit our website https://www.bioinc.org.